Skip to main content
. 2018 Apr 25;2018(4):CD011526. doi: 10.1002/14651858.CD011526.pub2
Methods Randomized controlled trial
Length of follow‐up: until recovery from diarrhoea
Participants Number: 90 enrolled children
Inclusion criteria: inpatients; well‐nourished male children aged 3 to 24 months with watery diarrhoea < 5 days duration, with dehydration of any severity
Exclusion criteria: prolonged diarrhoea, malnutrition, major illnesses
Breastfeeding: not specified
Interventions Intervention group: diosmectite. Dosage 1.5 g, 4 times daily for 3 days
Control group: placebo
Outcomes Duration of diarrhoea (from enrolment to last liquid stool)
Frequency of diarrhoea
Duration of vomiting
Feeding pattern
Notes Location: Egypt
Setting: urban
Cause of diarrhoea: rotavirus 16%. Other aetiologies not specified.
Source of funding: WHO and industry
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Block randomization by Diarrheal Disease Control Programme of the WHO
Allocation concealment (selection bias) Low risk Numerically coded envelopes
Blinding of participants and personnel (performance bias) All outcomes Low risk Use of placebo
Blinding of outcome assessment (detection bias) All outcomes Low risk Use of placebo
Incomplete outcome data (attrition bias) All outcomes Low risk No losses to follow‐up
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judgement. No protocol registered.
Other bias Low risk No other biases detected.